Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 35 (4)
Abstract
Li X, et al. J Gynecol Oncol. 2024 Jan;35:e42. https://doi.org/10.3802/jgo.2024.35.e42Keywords
Funding Information
- National Key Technology Research and Developmental Program of China (2022YFC2704400, 2022YFC2704401)
- Research and Development Fund of Peking University People’s Hospital (RDJP2023-19, RS2021-05, RDY2021-13, RDJP2022-09)
- National Natural Science Foundation of China (82103419, 82203568)
This publication has 32 references indexed in Scilit:
- Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestinGynecologic Oncology, 2014
- Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional studyGynecologic Oncology, 2014
- Endometrial progesterone resistance and PCOSJournal of Biomedical Science, 2014
- Insulin resistance: A significant risk factor of endometrial cancerGynecologic Oncology, 2012
- Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expressionJournal of Obstetrics and Gynaecology Research, 2012
- MetforminInternational Journal of Gynecological Cancer, 2012
- Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- The association between metabolic abnormality and endometrial cancer: A large case-control study in ChinaGynecologic Oncology, 2010
- Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional studyCardiovascular Diabetology, 2010
- Efficacy of Megestrol Acetate (Megace) in the Treatment of Patients With Early Endometrial Adenocarcinoma: Our Experiences With 21 PatientsInternational Journal of Gynecological Cancer, 2009